You don't have credit card details available. You will be redirected to update payment method page. Click OK to continue.
You need to be a full subscriber to access this feature of the Switzer Super Report. Click here to upgrade your subscription or read recently answered questions below
James Dunn is a freelance finance journalist and media consultant. James was founding editor of Shares magazine, and formerly, the personal investment editor at The Australian.
His first book, Share Investing for Dummies, was published by John Wiley & Co. in September 2002: a second edition was published in March 2007...View more >
Recently I came across these two stocks, that both start with the same letter, and sound very similar when spoken aloud. But they have three other things in common, as well. Read on…
Here are two ASX global leaders, both of which operate in specialist global technology fields, where they are very highly regarded: Appen and Audinate. I urge you to have a read.
Australia’s east coast continues to face a potential natural gas supply deficit, that’s likely to hurt both households and industries that use gas in industrial processes. Potential new sources ar..
Here’s a trio of micro-caps, in very different industries, that all look highly capable of delivering a 50% gain from current levels.
Here’s another collection of highly interesting stocks, laden with potential, from very different industries – but all currently under 50 cents in price.
Cancer is one of the most interesting areas of work of the ASX’s growing cohort of life sciences companies. Here are three of the fascinating stories emerging from this area.
